Composition
- Active ingredients
- NILOTINIB 200MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218532.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Nilotinib
- Drug class
- BCR-ABL tyrosine kinase inhibitors
- Group
- Kinase inhibitors
- Dosage form
- Capsule
- Applicant
- Torrent
- Status
- Tentative approval
- FDA approval
- 15 Dec 2025
- Application
- ANDA218532-003